Literature DB >> 32758526

Insights into dental mineralization from three heritable mineralization disorders.

Michael B Chavez1, Kaitrin Kramer2, Emily Y Chu3, Vivek Thumbigere-Math4, Brian L Foster5.   

Abstract

Teeth are comprised of three unique mineralized tissues, enamel, dentin, and cementum, that are susceptible to developmental defects similar to those affecting bone. X-linked hypophosphatemia (XLH), caused by PHEX mutations, leads to increased fibroblast growth factor 23 (FGF23)-driven hypophosphatemia and local extracellular matrix disturbances. Hypophosphatasia (HPP), caused by ALPL mutations, results in increased levels of inorganic pyrophosphate (PPi), a mineralization inhibitor. Generalized arterial calcification in infancy (GACI), caused by ENPP1 mutations, results in vascular calcification due to decreased PPi, later compounded by FGF23-driven hypophosphatemia. In this perspective, we compare and contrast dental defects in primary teeth associated with XLH, HPP, and GACI, briefly reviewing genetic and biochemical features of these disorders and findings of clinical and preclinical studies to date, including some of our own recent observations. The distinct dental defects associated with the three heritable mineralization disorders reflect unique processes of the respective dental hard tissues, revealing insights into their development and clues about pathological mechanisms underlying such disorders. Published by Elsevier Inc.

Entities:  

Keywords:  Cementum; Dentin; Enamel; Hypophosphatemia; Mineralized tissues

Year:  2020        PMID: 32758526      PMCID: PMC7530110          DOI: 10.1016/j.jsb.2020.107597

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  71 in total

Review 1.  Molecular and cellular biology of alveolar bone.

Authors:  J Sodek; M D McKee
Journal:  Periodontol 2000       Date:  2000-10       Impact factor: 7.589

Review 2.  Are cementoblasts a subpopulation of osteoblasts or a unique phenotype?

Authors:  D D Bosshardt
Journal:  J Dent Res       Date:  2005-05       Impact factor: 6.116

Review 3.  NPP-type ectophosphodiesterases: unity in diversity.

Authors:  Cristiana Stefan; Silvia Jansen; Mathieu Bollen
Journal:  Trends Biochem Sci       Date:  2005-10       Impact factor: 13.807

4.  Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Authors:  Erik A Imel; Francis H Glorieux; Michael P Whyte; Craig F Munns; Leanne M Ward; Ola Nilsson; Jill H Simmons; Raja Padidela; Noriyuki Namba; Hae Il Cheong; Pisit Pitukcheewanont; Etienne Sochett; Wolfgang Högler; Koji Muroya; Hiroyuki Tanaka; Gary S Gottesman; Andrew Biggin; Farzana Perwad; Meng Mao; Chao-Yin Chen; Alison Skrinar; Javier San Martin; Anthony A Portale
Journal:  Lancet       Date:  2019-05-16       Impact factor: 79.321

5.  A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.

Authors:  Karl L Insogna; Karine Briot; Erik A Imel; Peter Kamenický; Mary D Ruppe; Anthony A Portale; Thomas Weber; Pisit Pitukcheewanont; Hae Il Cheong; Suzanne Jan de Beur; Yasuo Imanishi; Nobuaki Ito; Robin H Lachmann; Hiroyuki Tanaka; Farzana Perwad; Lin Zhang; Chao-Yin Chen; Christina Theodore-Oklota; Matt Mealiffe; Javier San Martin; Thomas O Carpenter
Journal:  J Bone Miner Res       Date:  2018-06-26       Impact factor: 6.741

6.  Reduced Orthodontic Tooth Movement in Enpp1 Mutant Mice with Hypercementosis.

Authors:  M Wolf; M Ao; M B Chavez; T N Kolli; V Thumbigere-Math; K Becker; E Y Chu; A Jäger; M J Somerman; B L Foster
Journal:  J Dent Res       Date:  2018-03-13       Impact factor: 6.116

7.  Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.

Authors:  M Ao; M B Chavez; E Y Chu; K C Hemstreet; Y Yin; M C Yadav; J L Millán; L W Fisher; H A Goldberg; M J Somerman; B L Foster
Journal:  Bone       Date:  2017-09-01       Impact factor: 4.398

8.  Impaired mineral quality in dentin in X-linked hypophosphatemia.

Authors:  Benjamin R Coyac; Guillaume Falgayrac; Guillaume Penel; Alain Schmitt; Thorsten Schinke; Agnès Linglart; Marc D McKee; Catherine Chaussain; Claire Bardet
Journal:  Connect Tissue Res       Date:  2018-12       Impact factor: 3.417

Review 9.  Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.

Authors:  S A Bowden; B L Foster
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Disrupted Protein Expression and Altered Proteolytic Events in Hypophosphatemic Dentin Can Be Rescued by Dentin Matrix Protein 1.

Authors:  Elizabeth Guirado; Yinghua Chen; Ryan D Ross; Youbin Zhang; Catherine Chaussain; Anne George
Journal:  Front Physiol       Date:  2020-02-14       Impact factor: 4.566

View more
  4 in total

Review 1.  Between a rock and a hard place: Regulation of mineralization in the periodontium.

Authors:  Natalie L Andras; Fatma F Mohamed; Emily Y Chu; Brian L Foster
Journal:  Genesis       Date:  2022-04-23       Impact factor: 2.389

2.  Effects of Active Vitamin D or FGF23 Antibody on Hyp Mice Dentoalveolar Tissues.

Authors:  E J Lira Dos Santos; M B Chavez; M H Tan; F F Mohamed; T N Kolli; B L Foster; E S Liu
Journal:  J Dent Res       Date:  2021-04-27       Impact factor: 6.116

3.  Ablation of Pyrophosphate Regulators Promotes Periodontal Regeneration.

Authors:  A Nagasaki; K Nagasaki; E Y Chu; B D Kear; W D Tadesse; S E Ferebee; L Li; B L Foster; M J Somerman
Journal:  J Dent Res       Date:  2020-12-24       Impact factor: 8.924

4.  Mineralization Defects in the Primary Dentition Associated With X-Linked Hypophosphatemic Rickets.

Authors:  Delaney Clayton; Michael B Chavez; Michelle H Tan; Tamara N Kolli; Priscila A Giovani; Kimberly J Hammersmith; Sasigarn A Bowden; Brian L Foster
Journal:  JBMR Plus       Date:  2021-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.